GH18-004, An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
GH18-004, An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
批准号:
10907386
负责人:
KRISTY MURRAY
金额:
$70.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2024-09-14
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary. Emerging pathogens are global public health threats, with low to middle income countries in Central
America having disproportionately high risks for transmission due to large population centers, areas of extreme
poverty, and tropical climates. In Belize and El Salvador, more than 6.7 million people are at risk, with 2.3 million
living in poverty. Vector-borne, respiratory, and enteric pathogens are of high concern in these vulnerable
populations. Outbreaks of dengue virus (DENV) have occurred in this region since the 1970's, and the first
autochthonous cases of chikungunya virus (CHIKV) and Zika virus (ZIKV) were reported in 2014 and 2015,
respectively. With Aedes aegypti mosquito populations established throughout the region and lack of resources
for vector surveillance and control, transmission of these pathogens will continue to be sustained. Autochthonous
transmission of parasitic and bacterial vector-borne diseases also occur; however, the true incidence and
prevalence of these infections are not known. In deeply impoverished communities that lack public health
infrastructure, general health can be poor and malnutrition prevalent, leading to a higher risk of adverse
outcomes from respiratory and enteric pathogens. Outbreaks can overwhelm public health systems and severely
strain the current diagnostic and case management capacities at the local level. Collectively, endemic and
emerging pathogens continue to impact Central America. Considering 1.3 million tourists visit Belize each year
alone, the risk of introduction to the US is high. To combat these disease threats, we have convened a strong,
multi-disciplinary international team to create an acute febrile illness (AFI) surveillance network to detect
and diagnose vector-borne, respiratory, and enteric pathogens within sentinel hospitals in two high-risk
areas of Belize (Belize City) and El Salvador (Sonsonate). These sentinel sites are based in tertiary-care
hospitals where Baylor College of Medicine (BCM) has current, ongoing projects. The total population served by
these hospitals is approximately 829,000. This AFI sentinel surveillance system will work in tandem with
vector and animal reservoir surveillance to create a One Health approach to detecting and combating
disease threats. We will leverage the academic strengths of US institutions with world-renowned expertise in
tropical medicine, entomology, veterinary public health, and informatics: BCM, Texas A&M, University of South
Carolina, and Johns Hopkins University. We will collaboratively expand our clinical, education, and research
missions, working in tandem with stakeholders from the respective Ministries of Health, local universities, hospital
networks, CDC, PAHO, and other US- and Central America-based partners. This collaborative network will
provide a preeminent resource to Central America for capacity building, training, applied research, diagnostics,
and integrated real-time surveillance for emerging pathogens. Our overall goal is to maximize the ability to
understand, detect, and respond to infectious disease threats in a high-risk region. Our One Health-integrated
surveillance system based in Central America will strengthen our regional defenses against disease threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10462456
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10228537
-
项目类别:
-
资助金额:$90.83万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10630167
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10242607
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10414761
-
项目类别:
-
资助金额:$118.8万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
GH18-004, An Integrated One Health Approach to Detect and Respond to Emerging Disease Threats in High-Risk Regions of Central America
-
批准号:10000812
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2018
-
负责人:KRISTY MURRAY
-
依托单位:
Trypanosoma cruzi testing of Triatoma vectors in a likely endemic area of Southeast Texas
-
批准号:9087422
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2016
-
负责人:KRISTY MURRAY
-
依托单位:
Renal And Neurological Outcomes In Chronically Infected West Nile Virus Patients
-
批准号:8525671
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2011
-
负责人:KRISTY MURRAY
-
依托单位:
Renal And Neurological Outcomes In Chronically Infected West Nile Virus Patients
-
批准号:8534835
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2011
-
负责人:KRISTY MURRAY
-
依托单位:
Renal And Neurological Outcomes In Chronically Infected West Nile Virus Patients
-
批准号:8700313
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2011
-
负责人:KRISTY MURRAY
-
依托单位:
Renal And Neurological Outcomes In Chronically Infected West Nile Virus Patients
-
批准号:8026115
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:KRISTY MURRAY
-
依托单位:
Epidemiology of Arboviral Encephalomyelitis in Houston
-
批准号:7057783
-
项目类别:
-
资助金额:$12.11万
-
财政年份:2005
-
负责人:KRISTY MURRAY
-
依托单位:
VIRAL SEROPREVALENCE IN THE HOMELESS
-
批准号:7204645
-
项目类别:
-
资助金额:$17.31万
-
财政年份:2005
-
负责人:KRISTY MURRAY
-
依托单位:
Epidemiology of Arboviral Encephalomyelitis in Houston
-
批准号:6926335
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2005
-
负责人:KRISTY MURRAY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型蒽酚类化合物XYD004通过激活AHR缓解银屑病的作用及机制研究
-
批准号:2025JJ60573
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋骞
-
依托单位:
tiRNA-Val-TAC-004在胃癌进展中的作用机制及标志物价值研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:付敏
-
依托单位:
环状RNA hsa_circSERPINE2_004介导MSC衰老在老年性骨质 疏松症发病中的作用及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:旺姗
-
依托单位:
ADRQβ-004疫苗靶向α1D-AR调节交感神经失衡与改善肺动脉重构的机制研究
-
批准号:82070522
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:邱志华
-
依托单位:
CsERF004调控黄瓜双抗性分子机制的研究
-
批准号:31801871
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:刘东
-
依托单位:
Snail/p53结合抑制剂SN004的抗肿瘤作用及分子机制研究
-
批准号:81803033
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:李红玫
-
依托单位:
以CKLF1为新型药物靶标的发现及其抗缺血性损伤的系统性药理学研究
-
批准号:81730096
-
项目类别:重点项目
-
资助金额:290.0万元
-
批准年份:2017
-
负责人:陈乃宏
-
依托单位:
SMIP004/SMIP004-7系列线粒体抑制剂作用机制及应用于去势抵抗性前列腺癌治疗的潜力研究
-
批准号:81773771
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:Dieter A. Wolf
-
依托单位:
新型脑保护剂H004及其活性葡萄糖醛酸代谢产物的脑转运代谢机制及药代-药效学研究
-
批准号:81603190
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:盛莉
-
依托单位:
木质纤维素水解液中抑制剂对发酵性丝孢酵母T.fermentans HWZ004细胞生长和油脂积累的影响规律及其机理研究
-
批准号:31071559
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:吴虹
-
依托单位: